1. Home
  2. LABT vs BAOS Comparison

LABT vs BAOS Comparison

Compare LABT & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$2.56

Market Cap

4.6M

Sector

Health Care

ML Signal

N/A

BAOS

Baosheng Media Group Holdings

N/A

Current Price

$2.68

Market Cap

4.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
LABT
BAOS
Founded
N/A
2018
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
4.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LABT
BAOS
Price
$2.56
$2.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
276.0K
16.4K
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$1.98
52 Week High
$4.72
$5.40

Technical Indicators

Market Signals
Indicator
LABT
BAOS
Relative Strength Index (RSI) 31.54 51.97
Support Level $2.10 $2.53
Resistance Level N/A $2.82
Average True Range (ATR) 0.61 0.15
MACD -0.10 0.01
Stochastic Oscillator 19.85 84.85

Price Performance

Historical Comparison
LABT
BAOS

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd is a China-based online marketing solution provider. The company provides internet marketing, short-video and V-log marketing, content production and operation, e-commerce marketing, data platform services, and AI technology-related services. It also offers customized marketing solutions and channel marketing services through partnerships with internet platforms such as Tencent, Alibaba, ByteDance, and Kuaishou.

Share on Social Networks: